The global Influenza Vaccine market is expected to grow at a compound annual growth rate of 5.51% over the forecast period to reach a market size of US$5.754 billion in 2026 from US$3.953 billion in 2019. Developing mindfulness about medicine and avoidance of flu and an expanding number of government efforts will drive the development of the market in the future. The developing geriatric populace across the globe is additionally expected to expand the interest in influenza vaccines.